 | • レポートコード：MRC2012A4024 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ガバペンチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ガバペンチンの種類別市場規模（カプセル、タブレット）、用途別市場規模（てんかん、神経因性疼痛、むずむず脚症候群、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Sun Pharmaceutical、Mylan、Assertio Therapeutics、Apotex、TEVA、Intas、Novartis、Arbor Pharma、Aurobindo Pharma、Jiangsu Enhua、Amneal、Jiangsu Hengrui、Alkem、Marksans Pharma、Sailike、Glenmark、 ・地域別グローバル市場分析 2015年-2020年 ・ガバペンチンの北米市場（アメリカ、カナダ、メキシコ） ・ガバペンチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ガバペンチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ガバペンチンの南米市場（ブラジル、アルゼンチン） ・ガバペンチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：カプセル、タブレット ・用途別分析：てんかん、神経因性疼痛、むずむず脚症候群、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Gabapentin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Gabapentin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.7%% in the forecast period of 2020 to 2025 and will expected to reach USD 1637.8 million by 2025, from USD 1529.6 million in 2019.
Market segmentation
Gabapentin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gabapentin market has been segmented into
Capsule
Tablet
By Application, Gabapentin has been segmented into:
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gabapentin market presented in the report. This section sheds light on the sales growth of different regional and country-level Gabapentin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gabapentin market.
The report offers in-depth assessment of the growth and other aspects of the Gabapentin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Gabapentin Market Share Analysis
Gabapentin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gabapentin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gabapentin sales, revenue and market share for each player covered in this report.
The major players covered in Gabapentin are:
Pfizer
Sun Pharmaceutical
Mylan
Assertio Therapeutics
Apotex
TEVA
Intas
Novartis
Arbor Pharma
Aurobindo Pharma
Jiangsu Enhua
Amneal
Jiangsu Hengrui
Alkem
Marksans Pharma
Sailike
Glenmark
Among other players domestic and global, Gabapentin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gabapentin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gabapentin, with price, sales, revenue and global market share of Gabapentin in 2018 and 2019.
Chapter 3, the Gabapentin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gabapentin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gabapentin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gabapentin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Gabapentin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gabapentin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Capsule
1.2.3 Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Gabapentin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Overview of Global Gabapentin Market
1.4.1 Global Gabapentin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sun Pharmaceutical
2.2.1 Sun Pharmaceutical Details
2.2.2 Sun Pharmaceutical Major Business
2.2.3 Sun Pharmaceutical SWOT Analysis
2.2.4 Sun Pharmaceutical Product and Services
2.2.5 Sun Pharmaceutical Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan SWOT Analysis
2.3.4 Mylan Product and Services
2.3.5 Mylan Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Assertio Therapeutics
2.4.1 Assertio Therapeutics Details
2.4.2 Assertio Therapeutics Major Business
2.4.3 Assertio Therapeutics SWOT Analysis
2.4.4 Assertio Therapeutics Product and Services
2.4.5 Assertio Therapeutics Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Apotex
2.5.1 Apotex Details
2.5.2 Apotex Major Business
2.5.3 Apotex SWOT Analysis
2.5.4 Apotex Product and Services
2.5.5 Apotex Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 TEVA
2.6.1 TEVA Details
2.6.2 TEVA Major Business
2.6.3 TEVA Product and Services
2.6.4 TEVA Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Intas
2.7.1 Intas Details
2.7.2 Intas Major Business
2.7.3 Intas Product and Services
2.7.4 Intas Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Product and Services
2.8.4 Novartis Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Arbor Pharma
2.9.1 Arbor Pharma Details
2.9.2 Arbor Pharma Major Business
2.9.3 Arbor Pharma Product and Services
2.9.4 Arbor Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Aurobindo Pharma
2.10.1 Aurobindo Pharma Details
2.10.2 Aurobindo Pharma Major Business
2.10.3 Aurobindo Pharma Product and Services
2.10.4 Aurobindo Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Jiangsu Enhua
2.11.1 Jiangsu Enhua Details
2.11.2 Jiangsu Enhua Major Business
2.11.3 Jiangsu Enhua Product and Services
2.11.4 Jiangsu Enhua Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Amneal
2.12.1 Amneal Details
2.12.2 Amneal Major Business
2.12.3 Amneal Product and Services
2.12.4 Amneal Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Jiangsu Hengrui
2.13.1 Jiangsu Hengrui Details
2.13.2 Jiangsu Hengrui Major Business
2.13.3 Jiangsu Hengrui Product and Services
2.13.4 Jiangsu Hengrui Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Alkem
2.14.1 Alkem Details
2.14.2 Alkem Major Business
2.14.3 Alkem Product and Services
2.14.4 Alkem Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Marksans Pharma
2.15.1 Marksans Pharma Details
2.15.2 Marksans Pharma Major Business
2.15.3 Marksans Pharma Product and Services
2.15.4 Marksans Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Sailike
2.16.1 Sailike Details
2.16.2 Sailike Major Business
2.16.3 Sailike Product and Services
2.16.4 Sailike Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Glenmark
2.17.1 Glenmark Details
2.17.2 Glenmark Major Business
2.17.3 Glenmark Product and Services
2.17.4 Glenmark Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gabapentin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gabapentin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gabapentin Manufacturer Market Share in 2019
3.3.2 Top 6 Gabapentin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gabapentin Sales, Revenue and Market Share by Regions
4.1.1 Global Gabapentin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gabapentin Revenue and Market Share by Regions (2015-2020)
4.2 North America Gabapentin Sales and Growth Rate (2015-2020)
4.3 Europe Gabapentin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gabapentin Sales and Growth Rate (2015-2020)
4.5 South America Gabapentin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gabapentin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gabapentin Sales, Revenue and Market Share by Country
5.1.1 North America Gabapentin Sales and Market Share by Country (2015-2020)
5.1.2 North America Gabapentin Revenue and Market Share by Country (2015-2020)
5.2 United States Gabapentin Sales and Growth Rate (2015-2020)
5.3 Canada Gabapentin Sales and Growth Rate (2015-2020)
5.4 Mexico Gabapentin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gabapentin Sales, Revenue and Market Share by Country
6.1.1 Europe Gabapentin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gabapentin Revenue and Market Share by Country (2015-2020)
6.2 Germany Gabapentin Sales and Growth Rate (2015-2020)
6.3 UK Gabapentin Sales and Growth Rate (2015-2020)
6.4 France Gabapentin Sales and Growth Rate (2015-2020)
6.5 Russia Gabapentin Sales and Growth Rate (2015-2020)
6.6 Italy Gabapentin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gabapentin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gabapentin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gabapentin Revenue and Market Share by Regions (2015-2020)
7.2 China Gabapentin Sales and Growth Rate (2015-2020)
7.3 Japan Gabapentin Sales and Growth Rate (2015-2020)
7.4 Korea Gabapentin Sales and Growth Rate (2015-2020)
7.5 India Gabapentin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gabapentin Sales and Growth Rate (2015-2020)
7.7 Australia Gabapentin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gabapentin Sales, Revenue and Market Share by Country
8.1.1 South America Gabapentin Sales and Market Share by Country (2015-2020)
8.1.2 South America Gabapentin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gabapentin Sales and Growth Rate (2015-2020)
8.3 Argentina Gabapentin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gabapentin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gabapentin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gabapentin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gabapentin Sales and Growth Rate (2015-2020)
9.3 Turkey Gabapentin Sales and Growth Rate (2015-2020)
9.4 Egypt Gabapentin Sales and Growth Rate (2015-2020)
9.5 South Africa Gabapentin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gabapentin Sales and Market Share by Type (2015-2020)
10.2 Global Gabapentin Revenue and Market Share by Type (2015-2020)
10.3 Global Gabapentin Price by Type (2015-2020)
11 Global Gabapentin Market Segment by Application
11.1 Global Gabapentin Sales Market Share by Application (2015-2020)
11.2 Global Gabapentin Revenue Market Share by Application (2015-2020)
11.3 Global Gabapentin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gabapentin Sales, Revenue and Growth Rate (2021-2025)
12.2 Gabapentin Market Forecast by Regions (2021-2025)
12.2.1 North America Gabapentin Market Forecast (2021-2025)
12.2.2 Europe Gabapentin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gabapentin Market Forecast (2021-2025)
12.2.4 South America Gabapentin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gabapentin Market Forecast (2021-2025)
12.3 Gabapentin Market Forecast by Type (2021-2025)
12.3.1 Global Gabapentin Sales Forecast by Type (2021-2025)
12.3.2 Global Gabapentin Market Share Forecast by Type (2021-2025)
12.4 Gabapentin Market Forecast by Application (2021-2025)
12.4.1 Global Gabapentin Sales Forecast by Application (2021-2025)
12.4.2 Global Gabapentin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Gabapentin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gabapentin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gabapentin Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Gabapentin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Gabapentin Major Business
Table 10. Pfizer Gabapentin Total Revenue (USD Million) (2018-2019)
Table 11. Pfizer SWOT Analysis
Table 12. Pfizer Gabapentin Product and Services
Table 13. Pfizer Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 15. Sun Pharmaceutical Gabapentin Major Business
Table 16. Sun Pharmaceutical Gabapentin Total Revenue (USD Million) (2018-2019)
Table 17. Sun Pharmaceutical SWOT Analysis
Table 18. Sun Pharmaceutical Gabapentin Product and Services
Table 19. Sun Pharmaceutical Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Mylan Basic Information, Manufacturing Base and Competitors
Table 21. Mylan Gabapentin Major Business
Table 22. Mylan Gabapentin Total Revenue (USD Million) (2018-2019)
Table 23. Mylan SWOT Analysis
Table 24. Mylan Gabapentin Product and Services
Table 25. Mylan Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Assertio Therapeutics Basic Information, Manufacturing Base and Competitors
Table 27. Assertio Therapeutics Gabapentin Major Business
Table 28. Assertio Therapeutics Gabapentin Total Revenue (USD Million) (2018-2019)
Table 29. Assertio Therapeutics SWOT Analysis
Table 30. Assertio Therapeutics Gabapentin Product and Services
Table 31. Assertio Therapeutics Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Apotex Basic Information, Manufacturing Base and Competitors
Table 33. Apotex Gabapentin Major Business
Table 34. Apotex Gabapentin Total Revenue (USD Million) (2018-2019)
Table 35. Apotex SWOT Analysis
Table 36. Apotex Gabapentin Product and Services
Table 37. Apotex Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. TEVA Basic Information, Manufacturing Base and Competitors
Table 39. TEVA Gabapentin Major Business
Table 40. TEVA Gabapentin Total Revenue (USD Million) (2018-2019)
Table 41. TEVA SWOT Analysis
Table 42. TEVA Gabapentin Product and Services
Table 43. TEVA Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Intas Basic Information, Manufacturing Base and Competitors
Table 45. Intas Gabapentin Major Business
Table 46. Intas Gabapentin Total Revenue (USD Million) (2018-2019)
Table 47. Intas SWOT Analysis
Table 48. Intas Gabapentin Product and Services
Table 49. Intas Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Novartis Basic Information, Manufacturing Base and Competitors
Table 51. Novartis Gabapentin Major Business
Table 52. Novartis Gabapentin Total Revenue (USD Million) (2018-2019)
Table 53. Novartis SWOT Analysis
Table 54. Novartis Gabapentin Product and Services
Table 55. Novartis Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Arbor Pharma Basic Information, Manufacturing Base and Competitors
Table 57. Arbor Pharma Gabapentin Major Business
Table 58. Arbor Pharma Gabapentin Total Revenue (USD Million) (2018-2019)
Table 59. Arbor Pharma SWOT Analysis
Table 60. Arbor Pharma Gabapentin Product and Services
Table 61. Arbor Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 63. Aurobindo Pharma Gabapentin Major Business
Table 64. Aurobindo Pharma Gabapentin Total Revenue (USD Million) (2018-2019)
Table 65. Aurobindo Pharma SWOT Analysis
Table 66. Aurobindo Pharma Gabapentin Product and Services
Table 67. Aurobindo Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Jiangsu Enhua Basic Information, Manufacturing Base and Competitors
Table 69. Jiangsu Enhua Gabapentin Major Business
Table 70. Jiangsu Enhua Gabapentin Total Revenue (USD Million) (2018-2019)
Table 71. Jiangsu Enhua SWOT Analysis
Table 72. Jiangsu Enhua Gabapentin Product and Services
Table 73. Jiangsu Enhua Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Amneal Basic Information, Manufacturing Base and Competitors
Table 75. Amneal Gabapentin Major Business
Table 76. Amneal Gabapentin Total Revenue (USD Million) (2018-2019)
Table 77. Amneal SWOT Analysis
Table 78. Amneal Gabapentin Product and Services
Table 79. Amneal Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Jiangsu Hengrui Basic Information, Manufacturing Base and Competitors
Table 81. Jiangsu Hengrui Gabapentin Major Business
Table 82. Jiangsu Hengrui Gabapentin Total Revenue (USD Million) (2018-2019)
Table 83. Jiangsu Hengrui SWOT Analysis
Table 84. Jiangsu Hengrui Gabapentin Product and Services
Table 85. Jiangsu Hengrui Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Alkem Basic Information, Manufacturing Base and Competitors
Table 87. Alkem Gabapentin Major Business
Table 88. Alkem Gabapentin Total Revenue (USD Million) (2018-2019)
Table 89. Alkem SWOT Analysis
Table 90. Alkem Gabapentin Product and Services
Table 91. Alkem Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Marksans Pharma Basic Information, Manufacturing Base and Competitors
Table 93. Marksans Pharma Gabapentin Major Business
Table 94. Marksans Pharma Gabapentin Total Revenue (USD Million) (2018-2019)
Table 95. Marksans Pharma SWOT Analysis
Table 96. Marksans Pharma Gabapentin Product and Services
Table 97. Marksans Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Sailike Basic Information, Manufacturing Base and Competitors
Table 99. Sailike Gabapentin Major Business
Table 100. Sailike Gabapentin Total Revenue (USD Million) (2018-2019)
Table 101. Sailike SWOT Analysis
Table 102. Sailike Gabapentin Product and Services
Table 103. Sailike Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 104. Glenmark Basic Information, Manufacturing Base and Competitors
Table 105. Glenmark Gabapentin Major Business
Table 106. Glenmark Gabapentin Total Revenue (USD Million) (2018-2019)
Table 107. Glenmark SWOT Analysis
Table 108. Glenmark Gabapentin Product and Services
Table 109. Glenmark Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 110. Global Gabapentin Sales by Manufacturer (2018-2019) (K MT)
Table 111. Global Gabapentin Revenue by Manufacturer (2018-2019) (USD Million)
Table 112. Global Gabapentin Sales by Regions (2015-2020) (K MT)
Table 113. Global Gabapentin Sales Market Share by Regions (2015-2020)
Table 114. Global Gabapentin Revenue by Regions (2015-2020) (USD Million)
Table 115. North America Gabapentin Sales by Countries (2015-2020) (K MT)
Table 116. North America Gabapentin Sales Market Share by Countries (2015-2020)
Table 117. North America Gabapentin Revenue by Countries (2015-2020) (USD Million)
Table 118. North America Gabapentin Revenue Market Share by Countries (2015-2020)
Table 119. Europe Gabapentin Sales by Countries (2015-2020) (K MT)
Table 120. Europe Gabapentin Sales Market Share by Countries (2015-2020)
Table 121. Europe Gabapentin Revenue by Countries (2015-2020) (USD Million)
Table 122. Asia-Pacific Gabapentin Sales by Regions (2015-2020) (K MT)
Table 123. Asia-Pacific Gabapentin Sales Market Share by Regions (2015-2020)
Table 124. Asia-Pacific Gabapentin Revenue by Regions (2015-2020) (USD Million)
Table 125. South America Gabapentin Sales by Countries (2015-2020) (K MT)
Table 126. South America Gabapentin Sales Market Share by Countries (2015-2020)
Table 127. South America Gabapentin Revenue by Countries (2015-2020) (USD Million)
Table 128. South America Gabapentin Revenue Market Share by Countries (2015-2020)
Table 129. Middle East & Africa Gabapentin Sales by Countries (2015-2020) (K MT)
Table 130. Middle East & Africa Gabapentin Sales Market Share by Countries (2015-2020)
Table 131. Middle East & Africa Gabapentin Revenue by Countries (2015-2020) (USD Million)
Table 132. Middle East & Africa Gabapentin Revenue Market Share by Countries (2015-2020)
Table 133. Global Gabapentin Sales by Type (2015-2020) (K MT)
Table 134. Global Gabapentin Sales Share by Type (2015-2020)
Table 135. Global Gabapentin Revenue by Type (2015-2020) (USD Million)
Table 136. Global Gabapentin Revenue Share by Type (2015-2020)
Table 137. Global Gabapentin Sales by Application (2015-2020) (K MT)
Table 138. Global Gabapentin Sales Share by Application (2015-2020)
Table 139. Global Gabapentin Sales Forecast by Regions (2021-2025) (K MT)
Table 140. Global Gabapentin Market Share Forecast by Regions (2021-2025)
Table 141. Global Gabapentin Sales Forecast by Type (2021-2025) (K MT)
Table 142. Global Gabapentin Market Share Forecast by Type (2021-2025)
Table 143. Global Gabapentin Sales Forecast by Application (2021-2025)
Table 144. Global Gabapentin Market Share Forecast by Application (2021-2025)
Table 145. Direct Channel Pros & Cons
Table 146. Indirect Channel Pros & Cons
Table 147. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gabapentin Picture
Figure 2. Global Sales Market Share of Gabapentin by Type in 2019
Figure 3. Capsule Picture
Figure 4. Tablet Picture
Figure 5. Gabapentin Sales Market Share by Application in 2019
Figure 6. Epilepsy Picture
Figure 7. Neuropathic Pain Picture
Figure 8. Restless Legs Syndrome Picture
Figure 9. Others Picture
Figure 10. Global Gabapentin Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Gabapentin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Gabapentin Sales Market Share by Manufacturer in 2019
Figure 31. Global Gabapentin Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Gabapentin Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Gabapentin Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 36. Global Gabapentin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Gabapentin Revenue Market Share by Regions (2015-2020)
Figure 38. Global Gabapentin Revenue Market Share by Regions in 2018
Figure 39. North America Gabapentin Sales and Growth Rate (2015-2020)
Figure 40. Europe Gabapentin Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Gabapentin Sales and Growth Rate (2015-2020)
Figure 42. South America Gabapentin Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Gabapentin Sales and Growth Rate (2015-2020)
Figure 44. North America Gabapentin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Gabapentin Sales Market Share by Countries (2015-2020)
Figure 46. North America Gabapentin Sales Market Share by Countries in 2018
Figure 47. North America Gabapentin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Gabapentin Revenue Market Share by Countries in 2018
Figure 49. United States Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Canada Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Mexico Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Europe Gabapentin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Gabapentin Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Gabapentin Revenue Market Share by Countries in 2019
Figure 55. Germany Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 56. UK Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 57. France Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Russia Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Italy Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Asia-Pacific Gabapentin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Gabapentin Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Gabapentin Revenue Market Share by Regions 2019
Figure 63. China Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Japan Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Korea Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 66. India Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Southeast Asia Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 68. South America Gabapentin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Gabapentin Sales Market Share by Countries in 2019
Figure 70. South America Gabapentin Revenue Market Share by Countries in 2019
Figure 71. Brazil Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Argentina Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Middle East and Africa Gabapentin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Gabapentin Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Gabapentin Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Gabapentin Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Egypt Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Turkey Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 80. South Africa Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Global Gabapentin Sales and Growth Rate (2021-2025) (K MT)
Figure 82. Global Gabapentin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Gabapentin Market Forecast (2021-2025) (K MT)
Figure 84. Europe Sales Gabapentin Market Forecast (2021-2025) (K MT)
Figure 85. Asia-Pacific Sales Gabapentin Market Forecast (2021-2025) (K MT)
Figure 86. South America Sales Gabapentin Market Forecast (2021-2025) (K MT)
Figure 87. Middle East & Africa Sales Gabapentin Market Forecast (2021-2025) (K MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
神経因性疼痛治療薬の世界市場（～2026年） Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of value, North America is a large market and is expected to…- 小児てんかん治療薬の世界市場（～2026年） Epilepsy is one of the most common and challenging neurologic disorders affecting children. Pediatric epilepsies present particular challenges, including correct diagnoses, comorbidities and interactions with developmental processes in the brain. Market Analysis and Insights: Global Pediatric Epilep…
- 癲癇診断・治療の世界市場（～2026年） Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the …
- 癲癇治療の世界市場（～2026年） Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epileps…
- 癲癇治療薬の世界市場（～2026年） Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epileps…